Stakeholder institutions advise, guide, and support e efforts of TB Alliance. e TB Alliance Stakeholders Association (SHA) is an advisory committee which provides advice and support to on activities related to e research & development of anti-tuberculosis medicines and regimens. access to new TB products, e fulfilment of TBAlliance’s AAA Mandate – at all new products are adopted. eja outlined TB Alliance’s approach to address ese and o er concerns to enable rapid and widespread access to new TB regimens. SHA Secretary Paul Sommerfeld led a Q&A session in which stakeholders considered how e TB community can collaborate to improve conditions for e discovery, development and delivery of new TB drug erapies. e Stakeholders Association comprises institutions which have formally pledged to support e organization in its mission and signed e 2000 Cape Town laration which formed e TB Alliance. Since e input of e broader global heal community is an important component of e annual meeting, outside participants are welcome to join by invitation each year. 13, · e CR gives independent advice and feedback to e SHA and TB Alliance on all matters relating to TB drug research and development, and e introduction of new TB regimens. e CR is a voice for TB patients, participants in TB research, survivors, affected communities and advocates. TB Alliance Stakeholders Meeting Feedback Survey Question Title *. Please choose one of e following: I attended e recent Annual TB Alliance Stakeholders Meeting in e Hague, Ne erlands on ober 23, . , · Stakeholders Association Meeting. e Stakeholders Association (SHA) of e TB Alliance held its annual meeting on Tuesday, ober , ahead of e 48 Union World Conference on Lung Heal in Guadalajara, Mexico. Today, e development of new drugs for all forms of tuberculosis (TB) is at e forefront of efforts to end what is now e world’s deadliest infectious disease. e TB Alliance held its annual Stakeholders Association meeting in Paris, France on ober 28, ahead of e Union World Conference on Lung Heal. 90 participants attended to hear updates from e TB Alliance and discuss challenges and exciting new opportunities in e coming mon s and years. e meeting was presided over by Karl Hofmann, of PSI, e newly elected President of e Stakeholders Association and a member of e TB Alliance . TB Alliance is a not-for-profit organization dedicated to e discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs at are available to ose who need em. A New Treatment Accelerating e Pace. MMV's 14 Stakeholder meeting brought toge er respected malaria research and public heal experts from Indonesia and e global malaria community as well as funding partners. It provided a platform for ese key stakeholders to discuss challenges and e latest advances in . e GeneXpert MTB/RIF test from Cepheid HBDC, endorsed by e World Heal Organization (WHO) for roll-out in 20, has tremendous potential for improving TB diagnostic capacity and, as such, TB control in high-burden countries. e use of e GeneXpert MTB/RIF test is increasing exponentially at a global level. However, resource-constrained countries are faced wi some [ ]. 04, · An overview of TB Alliance's progress in developing new treatment regimens for tuberculosis. is video premiered at e Annual Meeting of TB Alliance's Stakeholders Association in . Global TB ket estimated. Q1 : PmRN endorses pediatric TB regulatory pa way. Q1 : WHO PQ approval. : Final products available in e ket. : Project Launch. Q1 : Global Stakeholders Meeting. Q2 : Dosage guidelines for children 5kg submitted to WHO PQ. Q4 : MOU signed wi first manufacturer. Beginning of e meeting. Introduction of participants. One minute’s silence in remembrance of people who died before ey could receive treatment. Beginning of presentation My name is Stephanie Seidel, I represent e organization TB-Alliance (hereinafter – TBA). My colleague, Sarah Cook-Scalise will also be present at is call. Host: Stop TB Partnership, UHC2030, WHO, Japan, UNAIDS, NCD Alliance Venue: West Terrace, Delegation Dining, UNHQ Time: 18:00-20:00 Participants: high level multi-stakeholder (invitation only) Wednesday 25 SDG Summit Day 2 Time: all day. Driving Momentum to Achieve Heal for All: A Toast to PHC for UHC Host: PHCPI, Amref. is session will bring toge er stakeholders from e field of pediatric TB to galvanize e action needed to speed adoption of new, appropriate child-friendly treatments. Find e e-invitation here and e full agenda here. TB Alliance, WHO, Stop TB Partnership, UNITAID and partners. 2:00 - 6:00 PM: PPM Core Group Meeting. Public Private Mix. 18, · TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on e TB Alliance's new drug application for pretomanid. In ch , e U.S. Food and Drug Administration (FDA) accepted a new drug application for pretomanid, a drug candidate developed by e TB Alliance. Dear partners! We are happy to inform you at ENPUD member, INPUD Board member, Global Fund Advocates Network Speakers Bureau member and Alliance for Public Heal employee, Anton Basenko, has, wi technical support of Regional Platform, successfully nominated by Alliance and ENPUD for participation in Stakeholder Task Force for e High Level Meeting and received an invitation . 26, · Toge er, Covid-19 and TB pose a deadly, dual reat - a syndemic at feeds on social inequities and poverty. Tremendous catch-up work, advocacy, and funding will be . Global Alliance for TB Drug Development Stakeholders Association Community Representative Call for Applications Deadline: ust 3, e Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit product development partnership (PDP) dedicated to e discovery and development of better, faster-acting. 30, · On 29 y , advocates sent an open letter to a group of stakeholders meeting in Italy, including donors and government representatives, to raise considerations related to pretomanid access and transparency, and concerns regarding e lack of community representation at e meeting. Fur er investments in pretomanid should be made responsibly, and include terms at promote . Stakeholder Meeting showcases e continuing Success of e European Lead Factory. On 13 ember , e first Stakeholder Meeting of e European Lead Factory (ELF) under e new ESCulab- TB Alliance) described e current T uberculosis (TB) pandemic. TB is e leading infectious disease killer, currently responsible for. 6 million. TB is preventable & curable: Zero new infection & zero dea s must become a reality TB is preventable, treatable and curable. Tuberculosis and Malaria (e Global Fund), and is e Communities Representative at e TB Alliance Stakeholders Association. Ending TB is not just about meeting a deadline but is essentially a human rights. 12, · New York —TB Alliance, a not-for-profit organization leading e development of new, improved and affordable tuberculosis (TB) treatments, today announced at its Stakeholders Association (SHA) has elected Mitchell ren as its president, a position at entails a seat on TB Alliance’s Board of Directors. An accomplished leader and advocate, ren brings extensive experience in accelerating e development and introduction of critical global heal in ations. Apr 15, · Most notably, she helped form e TB Alliance, a public-private partnership dedicated to e discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs. Wi support from Dr. Rouse and RTI, e TB Alliance received FDA approval in for a drug regimen at treats extensively drug resistant tuberculosis. e Stakeholders Association plays an integral role in shaping e work of TB Alliance, said Mel Spigelman, MD, president and CEO of TB Alliance. We are pleased to welcome Mitchell's leadership. e objectives of e stakeholder meeting on malaria were to: Review e current status and barriers to progress in e field of malaria research. Identify e key research areas where EDCTP support can have maximum impact. Highlight opportunities for European and African collaboration (Nor -Nor and Nor -Sou) at EDCTP can facilitate. 12, · ober 12, . While we still have a way to go before we arrive at a universal cure for is disease, we have building blocks coming rough e research pipeline at show us we can get ere, said Dr Mel Spigelman, President and CEO of TB Alliance, in e stakeholders' meeting covered by Citizen News Service. Guadalajara, Jalisco, Mexico - On e eve of e 48 Union World . Global heal and HIV/AIDS leader brings extensive experience in advancing critical global heal in ations. New York—TB Alliance, a not-for-profit organization leading e development of new, improved and affordable tuberculosis (TB) treatments, today announced at its Stakeholders Association (SHA) has elected Mitchell ren as its president, a position at entails a seat on TB. TB is preventable & curable: Zero new infection & zero dea s must become a reality BOBBY RAMAKANT – CNS TB is preventable, treatable and curable. Tuberculosis and Malaria (e Global Fund), and is e Communities Representative at e TB Alliance Stakeholders Association. Ending TB is not just about meeting a deadline but. ra er an because ey represent donor stake-holders. For e Global Alliance and MMV, ere is also an annual stakeholder’s meeting, equivalent to a companyshareholdermeeting,atwhich econcerns and viewpoints of stakeholders can be voiced. Since e partnerships are stand-alone and independent organizations, ey are accountable for. TB Alliance Access Case Study Access to in ative new products to treat poverty-related diseases requires a multi-faceted approach at strikes a balance between making e products available on an affordable basis and ensuring a reliable and sustainable supply of quality products. Feb 12, · NEW YORK, Feb. 12, /PRNewswire/ TB Alliance has appointed Dr. Daniel Everitt to e position of Vice President and Chief Medical Officer. In is role, Dr. Everitt will lead TB Alliance's development planning for lead drug candidates and el regimens and oversee e planning, design, and direction of all clinical trials. 15, · Last year, at e UN High Level Meeting on Tuberculosis, I spoke about e need to science e shit out of TB.Wi out in ation and ambition, we . • Attendance at annual GxP or o er applicable regulatory trainings provided by TB Alliance. • Communicate wi key scientific stakeholders in e organization, requiring a high level of Title: Research And Development . TB is preventable & curable: Zero new infection & zero dea s must become a reality. (e Global Fund), and is e Communities Representative at e TB Alliance Stakeholders Association. Why were people wi TB missing in e first place? Just recently we have been doing an exercise called finding missing TB cases. Ending TB is not. is high-level reception will bring partners and stakeholders toge er in preparation of e UN High Level Meeting Tods Ending TB in , and to discuss key outcomes from a newly launched report on drug resistant pa ogens and e TB drug pipeline. ursday 21 . In e 2009 e committee held a meeting wi stakeholders on Goal 5 in e National Vaccine Plan. Several emes surfaced during e meeting, reflecting areas of agreement about major challenges and opportunities in e field. e TB Alliance Product Development Partnership: Putting to Work for a Faster TB Cure. Presentation to e Global. COALITION AGAINST TB (PHILCAT), MEMBER OF TB ALLIANCE STAKEHOLDERS Tuberculosis kills one person every 15 seconds and infects one- ird of e world. E FOCUS OF OUR EFFORTS—A NEW FASTER DRUG A new TB drug will: • Shorten e total duration of effective treatment, • Improve e treatment of MDR-TB, which cannot be treated wi isoniazid. Government has invited e MDC Alliance and MDC-T to grace e SADC Anti-Sanctions commemorations set for 24 ober. Due to e Covid-19 pandemic, it remains unclear where e commemorations will. In-Person Strategy Meeting About e Forum e Stakeholder Forum on Antimicrobial Resistance is an organization of partners, from medical societies, to policy and community groups, to pharmaceutical companies, to e individual programs working in communities to combat e rising reat of antimicrobial resistance. Shobha Shukla, CNS (Citizen News Service): On e eve of e 48 Union World Conference on Lung Heal, being held in Guadalajara, Mexico, e Global Alliance for TB Drug Development (TB Alliance) announced e ongoing Phase-1 clinical studies for two new drugs for TB treatment, developed by it. Bo compounds have proceeded rough early pre-clinical development and were granted. Keystone Symposia, a non-profit organization dedicated to connecting e scientific community for e benefit of e world community and accelerating life science discovery, conducts scientific conferences on biomedical and life science topics in relaxing environments at catalyze information exchange and networking. Meetings are designed to encourage scientists to discuss e newest ideas. 05, · TB is preventable, treatable and curable. and is e Communities Representative at e TB Alliance Stakeholders Association. Ending TB is not just about meeting a deadline but. 6 hours ago · e BAZ invitation for applications represents an incremental step tods e opening of e airwaves so as to ensure at more citizens, including ose in ginalised and underrepresented communities, access information and media products. It is not by coincidence at is year’s all stakeholders meeting was held on ember 2, a day. 03, · e meeting was hosted by UNESCO Institute for Lifelong Learning and reviewed national education response plans and strategies in e context of e pandemic and explored how new partnerships, including wi e UNESCO-led Global Education Coalition, and wi e new Associate Members of e Alliance, could advance you and adult literacy.